Gemcitabine, used alone or in combination with other chemotherapy agents, seems to improve the quality of life for those with pancreatic cancer. Chemotherapy with gemcitabine improves symptoms, including pain, nausea, and vomiting in about 25% of patients. It also provides a modest increase in survival (usually only a few months).
Fluorouracil is not associated with a survival benefit. Cisplatin and some other drugs have been used in combination with gemcitabine, but are associated with more side effects.
These drugs should be used with caution in the elderly, and in those with liver or
kidney disease. The elderly are at an increased risk of side effects.